Congestive heart failure is treated with a combination of medications, lifestyle changes, and in some cases devices or surgery. The specific approach depends on how far the condition has progressed and how well the heart is pumping. For people with reduced pumping ability, a full medication regimen can add an estimated 6.3 years of survival compared to older, conventional treatment. Treatment won’t reverse the condition, but it can dramatically slow progression, reduce symptoms, and keep you out of the hospital.
How Heart Failure Is Classified
Doctors use two systems to describe heart failure, and both affect which treatments are recommended. The first is a staging system from the American Heart Association that tracks disease progression from A through D. Stage A means you’re at risk but have no structural heart problems yet. Stage B means there are early structural changes but no symptoms. Stage C is where most treatment discussions begin: you have or have had symptoms like shortness of breath, fatigue, or swelling. Stage D is advanced heart failure that disrupts daily life or requires hospitalization.
The second system, the NYHA functional classification, describes how much the condition limits your activity. Class I means ordinary activity doesn’t cause symptoms. Class II means you’re comfortable at rest but notice fatigue or breathlessness with regular activity. Class IV, the most severe, means symptoms are present even at rest.
Your treatment plan will be tailored to where you fall on both of these scales, and your doctor will reassess as your condition changes.
The Four Core Medication Classes
For heart failure with reduced ejection fraction (meaning the heart isn’t pumping out enough blood with each beat), guidelines call for four classes of medication used together. Each one has been proven to reduce both hospitalizations and death in large clinical trials, and the benefit of combining all four is substantially greater than using just one or two.
The first pillar blocks a hormonal system that causes blood vessels to tighten and the body to retain fluid. The preferred option in this class also helps the body break down a natural substance that relaxes blood vessels, giving a dual benefit. The second pillar, beta-blockers, slows the heart rate and reduces how hard the heart has to work. Over time, this can actually allow the heart muscle to partially recover. The third pillar blocks a hormone called aldosterone that drives fluid retention and scarring in the heart. The fourth and newest pillar was originally developed for diabetes but turned out to have powerful heart failure benefits: in clinical trials, these medications reduced the combined risk of worsening heart failure or cardiovascular death by 25 to 26 percent. A real-world database study found they were associated with a 23% lower risk of cardiovascular death specifically.
An analysis of major heart failure trials estimated that a 55-year-old patient on all four medication classes could gain 8.3 additional years free from cardiovascular death or heart failure hospitalization compared to conventional therapy. Getting on all four pillars, and at adequate doses, is one of the most important things you can do.
Sodium and Fluid Limits
When the heart can’t pump efficiently, the body compensates by holding onto fluid. Excess sodium makes this worse. Mayo Clinic guidelines suggest limiting salt intake to 2,000 milligrams per day and fluid intake to about 50 ounces per day, including water-rich foods like fruit. For reference, 2,000 mg of sodium is less than a single teaspoon of table salt, and 50 ounces is roughly six glasses of water.
This is one of the harder lifestyle changes to maintain because sodium is in almost everything. Restaurant meals, canned soups, deli meats, bread, and condiments are common culprits. Reading nutrition labels becomes essential. Many people find that after a few weeks of lower sodium intake, their taste adjusts and previously normal foods start to taste salty.
Daily Monitoring at Home
Weighing yourself every morning is one of the simplest and most effective ways to catch worsening heart failure early. The scale picks up fluid retention before you notice swelling or increased breathlessness. The American Heart Association flags a gain of more than two to three pounds in a 24-hour period, or more than five pounds in a week, as warning signs that fluid is building up and your treatment may need adjustment. Weigh yourself at the same time each morning, after using the bathroom and before eating, and keep a log to share with your care team.
Exercise and Physical Activity
It might seem counterintuitive, but regular physical activity is a core part of heart failure treatment. The key is starting slowly and building gradually. Cleveland Clinic recommends beginning with short walks, increasing your pace over the first three minutes until your breathing is slightly elevated but you can still hold a conversation. The goal is to work up to 30 to 45 minutes of walking per day, most days of the week, with rest breaks as needed.
Cardiac rehabilitation programs offer a structured, supervised way to start exercising safely. These programs monitor your heart rate and blood pressure during exercise and gradually increase the workload as your fitness improves. If a formal program isn’t available, your care team can help you design a home-based plan.
Devices for Advanced Heart Failure
When medications and lifestyle changes aren’t enough, implantable devices can help. Two are commonly used in heart failure treatment.
An implantable cardioverter-defibrillator (ICD) monitors heart rhythm and delivers a shock if a dangerous rhythm develops. Heart failure increases the risk of sudden cardiac arrest, and ICDs are typically considered when the heart’s pumping fraction drops to 35% or below despite being on optimal medications for at least three months.
Cardiac resynchronization therapy (CRT) uses a specialized pacemaker to coordinate the timing of the heart’s lower chambers so they pump together more efficiently. It’s generally recommended for patients whose electrical conduction is delayed, indicated by a wide pattern on an EKG (120 milliseconds or greater), combined with a low pumping fraction. For people who meet the criteria, CRT can improve symptoms, exercise capacity, and survival.
When Medications Stop Being Enough
Stage D, or advanced heart failure, means the condition significantly limits daily activities despite full medical therapy. At this point, the conversation shifts to more intensive options.
A left ventricular assist device (LVAD) is a mechanical pump surgically implanted to help the weakened heart move blood. Some people receive an LVAD as a bridge while waiting for a transplant. Others use it as long-term therapy when transplant isn’t an option. Living with an LVAD requires carrying external batteries and a controller, and the adjustment period can be significant, but many people return to meaningful daily activities.
Heart transplantation remains the most definitive treatment for end-stage heart failure, but eligibility is carefully evaluated. Factors that can disqualify someone include severe kidney or liver disease, active cancer, advanced diabetes with organ damage, and severe blood vessel disease in the legs or brain. Psychological readiness and a strong support system also factor into the evaluation. The shortage of donor hearts means wait times can be long, which is one reason LVADs play such an important role.
Newer Medications for Worsening Symptoms
For people who continue to deteriorate despite standard therapy, an additional medication that works by boosting a natural signaling molecule that relaxes blood vessels has shown promise. In a study of patients hospitalized with worsening heart failure and a pumping fraction of 45% or less, adding this drug cut the rate of rehospitalization for heart failure roughly in half over six months (16.3% vs. 34.2%). Patients also showed greater improvement in their functional class. The side effect profile was similar to standard treatment, with no significant increase in low blood pressure or kidney problems. This option is typically reserved for patients already on the four core medication classes who are still getting worse.